Topics

Venture Funding Deals: Tenaya's $92m, Nuvation's $275m Lead October Rounds

13:14 EST 8 Nov 2019 | SCRIP

Former Medivation CEO David Hung launched stealthy oncology start-up Nuvation with $275m in series A venture capital, while Tenaya's series...

      

Related Stories

 

Original Article: Venture Funding Deals: Tenaya's $92m, Nuvation's $275m Lead October Rounds

NEXT ARTICLE

More From BioPortfolio on "Venture Funding Deals: Tenaya's $92m, Nuvation's $275m Lead October Rounds"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...